Jul 24, 2015

AEAweb: JEP (29,1) p. 139 - Pricing in the Market for Anticancer Drugs

In 2011, Bristol-Myers Squibb set the price of its newly approved melanoma drug ipilimumab— brand name Yervoy—at $120,000 for a course of therapy. The drug was associated with an incremental increase in life expectancy of four months. Drugs like ipilimumab have fueled the perception that the launch prices of new anticancer drugs and other drugs in the so-called "specialty"...

Proceed to the page: http://linkis.com/eOoVs

Similar Articles Added Earlier

Similar Articles Added Today

Latest Links Processed